🔗 Permalink

Inventor profile of:

Bin Wang

City:

Brighton, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2019-11-07

Top Assignees for applications by Bin Wang

The entities that hold a legal rights for patent applications filed by inventor Wang Bin:

Enanta Pharmaceuticals, Inc. 18 Watertown, MA United States
Elmore Patent Law Group, P.C. 1 Watertown, MA United States

Recent patent applications by Wang Bin

Bin Wang from Brighton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-11-07

US20190337923A1

Chemistry; metallurgy

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#2 | 2019-08-29

US20190263860A1

Chemistry; metallurgy

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

#3 | 2019-06-27

US20190194216A1

Chemistry; metallurgy

Isoxazole analogs as FXR agonists and methods of use thereof

#4 | 2019-02-28

US20190062310A1

Chemistry; metallurgy

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#5 | 2018-12-20

US20180362503A1

Chemistry; metallurgy

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#6 | 2018-12-20

US20180362502A1

Chemistry; metallurgy

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#7 | 2018-12-20

US20180362501A1

Chemistry; metallurgy

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#8 | 2018-11-15

US20180327388A1

Chemistry; metallurgy

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

#9 | 2018-06-14

US20180162905A1

Chemistry; metallurgy

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

#10 | 2018-05-31

US20180148469A1

Chemistry; metallurgy

Process for preparation of sulfonylurea bile acid derivatives

#11 | 2018-05-24

US20180141941A1

Chemistry; metallurgy

Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof

#12 | 2018-04-12

US20180099957A1

Chemistry; metallurgy

Isoxazole analogs as FXR agonists and methods of use thereof

#13 | 2017-11-23

US20170334894A1

Chemistry; metallurgy

Isoxazole derivatives as FXR agonists and methods of use therof

#14 | 2017-11-23

US20170334893A1

Chemistry; metallurgy

Isoxazole analogs as FXR agonists and methods of use thereof

#15 | 2017-11-23

US20170333399A1

Human necessities

Isoxazole derivatives as FXR agonists and methods of use thereof

#16 | 2017-10-26

US20170304272A1

Human necessities

Isoxazole derivatives as FXR agonists and methods of use thereof

#17 | 2017-10-26

US20170304271A1

Human necessities

Isoxazole derivatives as FXR agonists and methods of use thereof

#18 | 2017-10-26

US20170304270A1

Human necessities

Isoxazole derivatives as FXR agonists and methods of use thereof

#19 | 2017-03-30

US20170088583A1

Chemistry; metallurgy

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

#20 | 2016-05-26

US20160145298A1

Chemistry; metallurgy

MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS

#21 | 2016-05-12

US20160130294A1

Chemistry; metallurgy

Deuterated nucleoside/tide derivatives

#22 | 2014-11-20

US20140341851A1

Chemistry; metallurgy

Benzimidazole derivatives

#23 | 2014-07-10

US20140194350A1

Human necessities

Macrocyclic proline derived HCV serine protease inhibitors

InventorID:

833112 ⎘